Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent. - Wikidata - wikimedia - TriplyDB

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

http://www.wikidata.org/entity/Q34513298

about

Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.Multidrug-resistant bacteria in hematology patients: emerging threats.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model.Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won't Cut It.Eravacycline for treatment of complicated intra-abdominal infections: the fire is not ignited!Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.Nonlinear Protein Binding: Not What You Think.Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis.Tetracycline-Inactivating Enzymes.Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits

P2860

Q33732524-5DD5C94A-A5A0-4D97-B7E4-E150192CEE8E Q36933389-F13CD539-6AFB-4433-A3AD-AE76E9B24F2D Q38838498-A9DDEE38-3B75-4ED1-A076-0A9C98F35AD2 Q38892589-31360218-C2D5-4D3B-B143-2B4E55903BE4 Q38958278-BB8A9C72-F682-4C68-9E44-5E471B56F9B2 Q40212540-6C42AD41-D312-47D0-B7AA-15C8A42ED1A7 Q40248088-40EB9019-327D-427C-A333-E2CEF9FDC1FB Q40346731-6EB4558C-0DBB-4F7F-95C9-DDD1AA11D934 Q45787274-146CE72A-F8E9-42AF-A047-78E3673E2EE3 Q47139448-92ADD61B-2077-4A21-A5DC-401FB6E5150E Q52601413-9E8D780E-0766-4EBB-8DA4-A6A4EAE1D9C6 Q52699619-4B6AE397-E461-46B6-9BEA-041E69EFACB5 Q55082798-A6215390-B144-4ABE-BFC8-A005A5005A2D Q57110876-674C50D5-51A7-45A1-BDE1-1668395DE7FB

P2860

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

http://www.wikidata.org/entity/Q34513298

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@ast

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@en

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@nl

type

label

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@ast

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@en

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@nl

prefLabel

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@ast

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@en

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@nl

P1433

Q34513298-01C6771B-797D-408D-A26E-526D8462E7EE

P1476

Q34513298-3143E6C1-8A58-4FBA-9669-BCEBFDB353CF

P2093

Q34513298-11009197-E1D0-4D08-A153-E561E1713555

Q34513298-3EDEC656-1255-40A7-926B-3672842D119C

Q34513298-96F22AD5-9E6D-468A-B5FB-CF0D01130169

Q34513298-AD0BBAE4-4455-435C-85E5-16D69AE980B7

Q34513298-DA88E2C4-69CD-4A78-B8B7-D2A1A26C485E

Q34513298-DB8AC27D-6D9E-42A5-82D8-16C71967C604

Q34513298-F32DBFA9-BC7C-4769-9EF2-0B78D9F12053

Q34513298-F8FB2729-BDCD-4816-B8D7-638131ED5A3E

Q34513298-FFEB4798-7127-484C-B7EA-B0399639C7DC

P2860

Q34513298-19B4793D-90CF-43C0-A53C-683A1B190507

Q34513298-19EB8043-8CA7-4B41-B8FC-42268A8D7F3F

Q34513298-1A6A67C0-698A-454E-B184-11D98D5B7C3D

Q34513298-20B20D01-3FE0-4D00-B562-AE91D89AB65D

Q34513298-251BB790-D233-40B2-81D7-EFDD0477FE4E

Q34513298-2EF65907-5CD1-4362-B6A6-94984CA8CF6F

Q34513298-357E6C17-3EFA-4B56-8444-2D67CBB6A48F

Q34513298-40604C33-8A66-47F2-9595-4D49C4FD0D9F

Q34513298-445F56FD-F489-46D0-B9FB-9A1F62265BAD

Q34513298-473BCD8A-2017-4616-AAEC-10D95F5DA015

P2888

Q34513298-1597B41A-1B40-49F8-807B-4635CA2D74CD

P304

Q34513298-FF08F132-EF58-48F3-983A-7954D81E6D25

P31

Q34513298-BF43AAEB-BCEA-4BF2-92A1-5BB2E69E35F2

P356

Q34513298-FD358ACE-AC86-4F48-B12E-388064A0C03D

P433

Q34513298-7C15DED5-33A9-4C58-8355-4FA3CD36066C

P478

Q34513298-F45A8564-80B4-4E33-82B5-F08C938EABFC

P50

Q34513298-2DA57777-70F7-43B2-BD2D-C03ABC012C6B

Q34513298-B759234A-C9C6-492C-975F-8B46D72666B2

Q34513298-E1F51EF3-7A5D-4ACD-9BF6-0B2D4290015F

P577

Q34513298-32D898F3-AEEE-45D8-84A9-6FB07624D115

P6179

Q34513298-2E493110-5EB3-43F7-AFBC-97F9970A76C6

P698

Q34513298-CB2F9BF6-4DA6-4DDE-8CE6-95572220B70F

P356

S40265-016-0545-8

P1433

P1476

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

@en

P2093

Alfred S Gin

http://www.w3.org/2001/XMLSchema#string

Andrew Walkty

http://www.w3.org/2001/XMLSchema#string

Bala Gorityala

http://www.w3.org/2001/XMLSchema#string

Daryl J Hoban

http://www.w3.org/2001/XMLSchema#string

Doris Cheung

http://www.w3.org/2001/XMLSchema#string

Frank Schweizer

http://www.w3.org/2001/XMLSchema#string

Heather Adam

http://www.w3.org/2001/XMLSchema#string

James A Karlowsky

http://www.w3.org/2001/XMLSchema#string

Philippe R S Lagacé-Wiens

http://www.w3.org/2001/XMLSchema#string

P2860

Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance

The glycylcyclines: a comparative review with the tetracyclines

A new tetracycline efflux gene, tet(40), is located in tandem with tet(O/32/O) in a human gut firmicute bacterium and in metagenomic library clones.

Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infections

Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.

The history of the tetracyclines.

Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.

TetAB46, a predicted heterodimeric ABC transporter conferring tetracycline resistance in Streptococcus australis isolated from the oral cavity.

Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City

Eravacycline (TP-434) is efficacious in animal models of infection.

P2888

s40265-016-0545-8

P304

567-588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0545-8

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Sheryl A. Zelenitsky

Alyssa R. Golden

George G Zhanel

P577

2016-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025384398

http://www.w3.org/2001/XMLSchema#string

P698

26863149

http://www.w3.org/2001/XMLSchema#string